Dolly A. Vance

2014

In 2014, Dolly A. Vance earned a total compensation of $1.1M as Executive Vice President, Corporate Affairs, General Counsel and Corporate Secretary at Rigel Pharmaceuticals.

Compensation breakdown

Option Awards$653,575
Salary$475,548
Other$3,042
Total$1,132,165

Vance received $653.6K in option awards, accounting for 58% of the total pay in 2014.

Vance also received $475.5K in salary and $3K in other compensation.

Rankings

In 2014, Dolly A. Vance's compensation ranked 7,033rd out of 13,032 executives tracked by ExecPay. In other words, Vance earned more than 46.0% of executives.

ClassificationRankingPercentile
All
7,033
out of 13,032
46th
Division
Manufacturing
2,586
out of 4,965
48th
Major group
Chemicals And Allied Products
879
out of 1,690
48th
Industry group
Drugs
692
out of 1,369
50th
Industry
Pharmaceutical Preparations
529
out of 1,042
49th
Source: SEC filing on March 29, 2017.

Vance's colleagues

We found five more compensation records of executives who worked with Dolly A. Vance at Rigel Pharmaceuticals in 2014.

2014

James Gower

Rigel Pharmaceuticals

Chief Executive Officer

2014

Donald Payan

Rigel Pharmaceuticals

Executive Vice President, of Discovery and Research

2014

Raul Rodriguez

Rigel Pharmaceuticals

Chief Executive Officer

2014

Elliott Grossbard

Rigel Pharmaceuticals

Chief Medical Officer

2014

Ryan Maynard

Rigel Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like